Related Experiment Video

Updated: Jun 21, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

[Combination therapy of ARB with diuretics in Japanese hypertensive patients]

Takuya Tsuchihashi1

  • 1Division of Hypertension, National Kyushu Medical Center.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 14, 2009
PubMed

Insights

Japanese hypertension guidelines recommend strict blood pressure control. Combination therapy with angiotensin receptor blockers (ARBs) and diuretics, like Losartan/HCTZ, effectively lowers blood pressure and manages metabolic risks.

Area of Science:

  • Cardiology
  • Pharmacology
  • Nephrology

Context:

  • The Japanese Society of Hypertension (JSH2009) guideline stresses stringent blood pressure (BP) control.
  • Current treatments using calcium channel blockers (CCBs) and angiotensin receptor blockers (ARBs) show insufficient BP control in Japan.
  • Dietary salt restriction (<6 g/day) is challenging for Japanese hypertensive patients.

Purpose:

  • To evaluate the efficacy of combination therapy for hypertension management in a Japanese population.
  • To address the challenges of achieving strict BP control and managing metabolic comorbidities.
  • To explore strategies for minimizing diuretic side effects in hypertensive patients.

Summary:

  • Low-dose diuretics are beneficial when salt restriction is difficult.
  • Combination therapy with ARBs or ACE inhibitors is recommended to mitigate diuretic-induced metabolic side effects.
  • Losartan/HCTZ combination tablets effectively reduce BP and Losartan may counteract HCTZ-induced hyperuricemia.

Impact:

  • Highlights the importance of tailored combination therapies for effective hypertension management.
  • Emphasizes the need for simultaneous control of metabolic risk factors (diabetes, dyslipidemia, hyperuricemia) to prevent cardiovascular events.
  • Provides evidence for the utility of Losartan/HCTZ in improving BP control and metabolic profiles in hypertensive patients.

More Related Videos

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...